Pharmaceutical products
Originaltitel der Bekanntmachung
Germany-Hamburg: Pharmaceutical products
Opportunity Score
Warum diese Bewertung?
Chance
65 / 100
Komplexität
40 / 100
Risikofaktoren
The procedure is a voluntary transparency notice, not a public contract under EU directives. Bidders have no procuremen...
No estimated value or guaranteed volume means uncertain revenue. Discounts may be substantial and profitability depends...
No procurement documents available
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Überblick
Strong opportunityWichtige Fakten
- Supplies contract
- 3 lots
- Supply of pharmaceutical products under non-exclusive discount agreements for specified active substances.
- Agreements aim to bridge the period between patent expiry and exclusive discount contracts.
Vollständige Zusammenfassung anzeigen
Open house procedure for non-exclusive discount agreements (Rabattverträge) under §130a Abs. 8 SGB V for pharmaceutical products. The notice is a voluntary transparency notice, not a public procurement subject to EU directives. The procedure is open to all qualified pharmaceutical entrepreneurs, with contracts awarded to all who meet the requirements. The contract runs from 1 November 2023 to 31 October 2026, with a possible 6-month extension. Ten lots cover various active substances. No estimated value is provided. Submission of participation and contract documents is electronic via the portal, with continuous accession possible during the contract term.
Risiken
The procedure is a voluntary transparency notice, not a public contract under EU directives. Bidders have no procuremen...
No estimated value or guaranteed volume means uncertain revenue. Discounts may be substantial and profitability depends...
No procurement documents available
Analyse kann unvollständig sein
Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.
Wichtige Anforderungen
Administrative
- Participation is open to pharmaceutical entrepreneurs (as defined in §4 Abs. 18 AMG) who submit a declaration of suitability and reliability.
- Bid submission via electronic portal; documents must be submitted with qualified electronic signature or signed original.
- For timely inclusion of discount pricing in pharmacy software, complete documents must be received by the 3rd of the month prior to the desired start month.
Anforderungen können unvollständig sein.
Auftraggeber
Ort
Karlsruhe, DEU
Website
Tätigkeit
Defence
Lose (3)
01
Carbamazepine (RET, N1, N2, N3) - TK, HEK, hkk
Discount agreement for Carbamazepine in specified forms, for participating health insurance funds TK, HEK, and hkk.
Kategorie
Frist
02
Ciclosporin (WKA) - TK, HEK, hkk
Discount agreement for Ciclosporin in specified form, for TK, HEK, hkk.
Kategorie
Frist
03
Levothyroxine sodium (excluding WKA, LSE, TRO, ILO) - TK
Discount agreement for Levothyroxine sodium in specified forms, for TK only.
Kategorie
Frist
Vergabedetails
- Veröffentlichungsdatum
- 19 Sep 2023
- Sprachen
- German
Referenzmetadaten
- Rechtsgrundlage
- 32014L0024
Referenz-IDs
- Ausschreibungs-ID
- 566780-2023
Ähnliche Ausschreibungen
Poland – Furniture – DZP.242.306.2026 Sukcesywny zakup wyposażenia meblowego wraz z dostawą, montażem i ustawieniem w pomieszczeniach Uniwersyteckiego Szpitala Klinicznego we Wrocławiu
Greece – Installation of cable laying – Προμήθεια υλικών και πλήρης κατασκευή της εναέριας Γ.Μ. 400kV ΚΥΤ ΝΕΑΣ ΣΑΝΤΑΣ – ΚΥΤ ΦΙΛΙΠΠΩΝ
Germany – Installation of doors and windows and related components – Tischlerarbeiten - Innentüren DIN 18355
Czechia – Portable computers – OPST – Konektivita, HW, SW, vybavení středních škol v Ústeckém kraji – SPŠ ÚL, Resslova – Koncové prvky II.
Poland – Electricity, heating, solar and nuclear energy – Świecka Grupa Zakupowa. Dostawa energii elektrycznej w okresie od 01.01.2027r. do 31.12.2027r.
Croatia – Restructuring work – Izvođenje radova na rekonstrukciji i dogradnji Konjičkog centra
Opportunity Score
Warum diese Bewertung?
Chance
65 / 100
Komplexität
40 / 100
Risikofaktoren
The procedure is a voluntary transparency notice, not a public contract under EU directives. Bidders have no procuremen...
No estimated value or guaranteed volume means uncertain revenue. Discounts may be substantial and profitability depends...
No procurement documents available
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications